Biotech & pharma
Lab-grown meat would 'cut emissions and save energy'
21 Jun 2011
Meat grown using tissue engineering techniques, so-called ‘cultured meat’, would generate up to 96% lower greenhouse gas emissions than conventionally produced meat, according to a new study
Nanoparticles disguised as red blood cells to deliver cancer-fighting drugs
By By Catherine Hockmuth | 21 Jun 2011
The method involves collecting the membrane from a red blood cell and wrapping it like a powerful camouflaging cloak around a biodegradable polymer nanoparticle stuffed with a cocktail of small molecule drugs
Swarming nanoparticles communicate to boost drug concentrations near tumours
By By Susan Brown | 21 Jun 2011
New breakthrough in high blood pressure research
17 Jun 2011
TRC researchers isolate new molecule to fight TB
16 Jun 2011
Why we are so complicated
16 Jun 2011
The complex web of protein interactions in our cells may be masking an ever-worsening problem.
"Chemobath" for colon cancer undergoes evaluation
By By Jackie Carr | 11 Jun 2011
Trapping deadly human viruses using decoys
08 Jun 2011
Major breakthrough in shrimp research at Andhra Pradesh
07 Jun 2011
The technology involves sex reversal of scampi males into functional females through microsurgical intervention and mating them with normal males to produce all-male progeny
Neutrons provide first sub-nanoscale snapshots of Huntington's disease protein
By By Agatha Bardoel | 06 Jun 2011
Advances in chemical synthesis reveal rare natural product with potent pain-killing properties
03 Jun 2011
Potential new drug candidate found for Alzheimer's disease
By By Debra Kain | 01 Jun 2011
Pancreas betrayed by 'double agent'
30 May 2011
How shifts in temperature primes immune response
By By Laura Bonetta | 28 May 2011
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
